ASE Technology (ASX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Consolidated revenues grew 2% year-over-year in 2024, with ATM revenues up 3% and testing business up 9%.
Leading-edge advanced packaging and testing revenues exceeded $600 million in 2024, up from $250 million in 2023, and are projected to add another $1 billion in 2025.
Machinery CapEx reached $1.9 billion in 2024, mainly for advanced packaging and testing.
Testing business grew 9% year-over-year in 2024 and 18% in Q4, with further acceleration expected in 2025.
Full-year 2024 net income rose 2% to NT$32,483 million; basic EPS was NT$7.52.
Financial highlights
FY2024 net revenues: NT$595,410 million, up 2.3% year-over-year; gross profit: NT$96,932 million, up 6%.
Q4 2024 net revenues: NT$162,264 million, up 1% year-over-year; gross profit: NT$26,631 million, up 3%.
Q4 net income was NT$9,312 million, down 1% year-over-year; basic EPS: NT$2.15.
Adjusted (excluding PPA) FY2024 net income: NT$36,905 million; basic EPS: NT$8.54.
Q4 2024 EBITDA: NT$28,797 million; full-year 2024 EBITDA: NT$112,612 million.
Outlook and guidance
2025 ATM revenues expected to grow above mid-single digits, outpacing the logic semiconductor market.
Leading-edge advanced packaging and testing revenues projected to increase by $1 billion in 2025, contributing about 10% growth.
2025 CapEx for machinery and equipment to match Q4 2024 annualized levels, with 60% for leading-edge and over 30% for testing.
ATM gross margin expected to recover to the structural target of 24%-30% in 2025, with further profitability improvement in 2026.
Continued expansion in R&D, human capital, advanced capacity, and smart factory investments.
Latest events from ASE Technology
- Strong 2025 results and robust 2026 outlook driven by AI, advanced packaging, and margin gains.ASX
Q4 20255 Feb 2026 - Q2 2024 net income rose to NT$7.8B on higher revenues and strong leading-edge demand.ASX
Q2 20243 Feb 2026 - Q3 2024 net income rose to NT$9,666m on strong packaging, test, and capex for future growth.ASX
Q3 202417 Jan 2026 - Q1 2025 net income up 33% year-over-year; ATM drives growth, EMS faces softness.ASX
Q1 202520 Dec 2025 - 7–9% revenue growth in H1/Q2 2025, led by advanced packaging and testing momentum.ASX
Q2 20256 Nov 2025 - Q3 2025 net income rose to NT$10,870 million on 11.8% sequential revenue growth, led by ATM.ASX
Q3 202530 Oct 2025